Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension

Hypertension

Volumn 28, Issue 1, 1996, Pages 22-30

  Nishikimi, Toshio ^a   Yoshihara, Fumiki ^a   Morimoto, Atsushi ^a   Ishikawa, Kazuhiko ^a   Ishimitsu, Toshihiko ^a   Saito, Yoshihiko ^a   Kangawa, Kenji ^a   Matsuo, Hisayuki ^a   Omae, Teruo ^a   Matsuoka, Hiroaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

hypertension, essential; hypertrophy; natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

EID: 8944237000     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.1.22     Document Type: Article

References (41)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990; 322:1561-1566.
2. Ganau A, Devereux RB, Roman MJ, Simone G, Pickering TG, Saba PS, Vargiu P, Simogini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114:345-352.
4. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens. 1995;13:155-160.
5. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815-820.
6. Devereux RB, Casale PN, Eisenberg RR, Miller DH, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard: comparison of standard criteria, computer diagnosis and physician interpretation. J Am Coll Cardiol. 1984; 3:82-87.
7. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
8. Needleman P, Greenwald JE. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. N Engl J Med. 1986;314:828-834.
9. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet. 1986;1:179-181.
10. Sugawara A, Nakao K, Sakamoto M, Morii N, Yamada T, Itoh H, Shiono S, Imura H. Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet. 1985;1426-1427.
11. MacDonald TM, Jeffrey RF, Lee MR. Atrial natriuretic peptides in essential hypertension. Lancet. 1986;1:562.
12. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature, 1988;332:78-81.
13. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Yasue H, Kanbayashi Y, Inoue K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest. 1991;87:1402-1412.
14. Monta E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88:82-91.
15. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet. 1993; 341:1109-1113.
16. Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, Mukoyama M, Nakao K, Imura H, Sasayama S. Ventricular expression of natriuretic peptide in hypertrophic cardiomyopathy. Circulation. 1993;88:372-380.
17. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor AM. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens. 1993;7:245-250.
18. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara M, Takeda T. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92:29-34.
19. Naruse M, Takeyama Y, Tanabe A, Hiroshige J, Naruse K, Yoshimoto T, Tanaka M, Katagiri T, Demura H. Atrial and brain natriuretic peptides in cardiovascular disease. Hypertension. 1994;23(suppl I): I-231-I-234.
20. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H. Human brain natriuretic peptide, a novel cardiac hormone. Lancet. 1990;335:801-802.
21. Montorsi P, Tonolo G, Polonia J, Hepburn D, Richard M. Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension. 1987;10:570-576.
22. Hama N, Nakao K, Mukoyama M, Suga S, Ogawa Y, Kawabata Y, Sugawara A, Imura H. Fundamental and clinical evaluation of 'Shionoria ANP,' human atrial natriuretic peptide IRMA kit. Clin Report. 1991;25:455-462.
23. Kono M, Yamauchi A, Tsuji T, Misaki A, Igano K, Ueki K, Fujishima M, Ueda A, Inoue K, Nakao K, Imura H. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku. 1993;13:2-7.
24. Yasue H, Yoshimura M, Jougasaki M, Itoh H, Suga S, Ogawa Y, Nakao K. Plasma levels of brain natriuretic peptide in normal subjects and patients with chronic heart failure: measurement by immunoradiometric assay (IRMA). Horm Clin. 1993;41:397-403.
25. Yasue H, Yoshimura M, Jougasaki M, Itoh H, Suga S, Ogawa Y, Nakao K. Plasma levels of brain natriuretic peptide in patients with acute myocardial infarction: measurement by immunoradiometric assay (IRMA). Horm Clin. 1993;41:405-409.
26. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
27. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 1977;55:613-618.
28. Diazumba SB, Dipette DJ, Comman C, Weber E, Joyner CR. Left ventricular filling characteristics in mild untreated hypertension. Hypertension. 1986;8(suppl I):I-156-I-160.
29. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3:1500-1506.
30. Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest. 1985;76:1705-1709.
31. Hirata Y, Ishii M, Fukui K, Hayakawa H, Namba S, Dan Y, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H. A possible physiological role of atrial natriuretic peptide in body fluid volume regulation. J Cardiovasc Pharmacol. 1989; 13(suppl6):S63-S68.
32. Rascher W, Tulassay T, Rang RE. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet. 1985;2:303.
33. Yasue H, Yoshimura M, Shimada H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
34. Solomon LR, Atherton JC, Bobinski H, Green R. Effect of posture on plasma immunoreactive atrial natriuretic polypeptide concentrations in man. Clin Sci. 1986;71:299-305.
35. Nishikimi T, Kohno M, Itagane H, Hirota K, Teragaki M, Akioka K, Yasuda M, Oku H, Takeuchi K, Takeda T. Influence of exercise on plasma atrial natriuretic factor levels in patients with myocardial infarction. Am Heart J. 1988;115:753-760.
36. Roman MJ, Devereux RB, Atras SA, Pini R, Ganau A, Hochreiter C, Niles NW, Borer JS, Laragh JH. Relationship of atrial natriuretic factor to left ventricular volume and mass. Am Heart J. 1989; 118:1236-1242.
37. Lang CC, Prasad N, McAlpine HM, Macleod C, Lipworth BJ, MacDonald TM. Struthers AD. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J. 1994;127:1635-1636.
38. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. J Clin Invest. 1995;96:1280-1287.
39. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995;91:698-706.
40. Chien Y, Frohlich ED. Reversal of left ventricular and cardiac performance. Curr Opin Cardiol. 1991;6:716-723.
41. Kannel WB, D'Agostino RB, Levy D, Belanger AJ. Prognostic significance of regression of left ventricular hypertrophy. Circulation. 1988;789(suppl II):II-89. Abstract.